 |
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2008, vol. 14, book 2
Subject Collection: Oral and Dental Medicine
Page: 41-44
DOI: 10.5272/jimab.14-2-2008.41
Online date: 8 August 2008
J of IMAB 2008; 14(2):41-44
SALIVARY COMPONENTS OF TREATED CANCER PATIENTS AND PATIENTS WITH PRECANCEROUS LESIONS
Asya Krasteva1, E. Aleksiev2, A. Ivanova3, I. Altankova4, T. Bocheva4, P. Stanimirov2, A. Bobeva2, N. Janev2, A. Kisselova1
1) Department of Oral Diagnostic and Maxillofacial Radiology, Faculty of Dental Medicine, Sofia;
2) Specialized University Hospital for Active Treatment in Maxillofacial Surgery, Sofia;
3) Clinic of Gastroenterology, "St. Ivan Rilski" University Hospital, Sofia;
4
) Laboratory of Immunology, “St. Ivan Rilski” University Hospital,
Medical University, Sofia, Bulgaria
ABSTRACT:
Oral squamous cell carcinoma (OSCC) accounts for nearly 50 % of all newly diagnosed cancers in India. In Bulgaria OSCC reaches nearly 75% of malignant tumours in the oral cavity (Ugrinov, 2006). The prognosis of this cancer remains relatively unchanged for the past 30 years, despite advances in diagnosis and management.
Salivary analysis holds promise as a non-invasive approach to identify biomarkers for human oral cancer. Salivary levels of immunoglobulins and acute phase proteins may have significant prognostic value in early cancer diagnostics.
Key words: saliva, oral cancer patients, proteins.
- Download FULL TEXT (PDF - 557 KB)
Please cite this article as:
Krasteva A, Aleksiev E, Ivanova A, Altankova I, Bocheva T, Stanimirov P, Bobeva A, Janev N, Kisselova A. SALIVARY COMPONENTS OF TREATED CANCER PATIENTS AND PATIENTS WITH PRECANCEROUS LESIONS. J of IMAB. 2008; 14(2):41-44. DOI: 10.5272/jimab.14-2-2008.41
REFERENCES:
1. Brown, A.M., Lally ET, Frankel A, Harwick R, Davis LW, Rominger CJ. The association of the IGA levels of serum and whole saliva with the progression of oral cancer. Cancer 1975; 35:1154-62.
2. Chen, P., Zhonghua Er., Bi Yan, Hou Ke, Za Zhi. Serum acute phase proteins in nasopharyngeal carcinoma and laryngeal cancers 1989;24:174-6.
3. Christodoulides, N., Mohanty S, Miller CS, Langub MC, Floriano PN, Ali MF et al. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 2005;5:261-9.
4. Dawes, C., Weatherell JA. Kinetics of fluoride in the oral fluids. J Dent Res. 1990;69:638-44.
5. De Souza, R.M., Lehn Cn, Denardin OV. Serumand salivary immunoglobulin A levels in patients with cancer of the mouth and oropharynx. Rev Assoc Med 2003;49:40-4.
6. Evrin, P.E., Nilsson SE, Oberg T, Malmberg B.Serum C-reactive protein in elderly men and women: association with mortality, morbidity and various biochemical values. Scand J Clin Lab Invest. 2005;65(1):23-31.)
7. Gleeson, M., Gripps AW,Clancy RL. Modifiers of thehuman mucosal immune system. Immunol Cell Biol 1995;73:397-404.
8. Gockel, I., Dirksen K, Messow CM, Junginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 2006;21;12:3746-50
9. Grimoud, A.M., Pontet F, Rousselet F, Lodter JP, Duffaut D, Seguela JP. Comparison of protein concentrations in saliva and serum. Ann Biol Clin 1988;46:361-70.
10. Hirasaki, S, Yamazaki T, Shiba K. Changes in salivary components by drug administration in patients with heart diseases. J Med Dent Sci 2005;52:183-8.
11. Hu, S., Yu T, Xie Y, Yang Y, Li Y, Zhou X et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007;4:55-64.
12. Kugler, J., Hess M, Haake D. Secretion of salivary immunoglobulin A in relation to age, saliva flow, mood state, secretion of albumin, cortisol, and catecholamines in saliva. J Clin immunol 1992; 12:45-9.
13. Nagler, R., Dayan D. The dual role of saliva in oral carcinogenesis. Oncology. 2006;71:10-7.
14. Parkin, M., Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
15. Parra, M.D., Tecles F, Martinez-Subiela S, Ceron JJ. C-reactive protein measurement in canine saliva. J Vet Diagn Invest 2005;17:139-44.
16. Shpitzer, Th., Bahar G, Feinmesser R, Nagler R M. A comprehensive salivary analysis for oral cancr diagnosis. J Cancer Res Clin Oncol 2007;133:613-7.
17. Ugrinov, R., Georgieva K, Kavlakov P, Svestarov V, Tenchev P, Bochev V et al. Malignant tumours of lips and oral mucosa. In: Maxillo – Facial and Oral Surgery (in Bulgarian), Kivi Publishing Group, Sofia 2006;509-16.
18. V. Vucicevic, N. Cikes ,J Lukas, M Virag, A Cekic-Arambasin. Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patuents with oral squamous cell carcinoma. Minerva Stomatol 2005; 54:569-73.
19. Watanabe, T., Iglehart JD, Bolognesi DP. Secretory immune response in patients with oropharyngeal carcinoma. Ann Otol Rhinol Laryngol 1983;92:295-9.
20. Zhao, C., Annamalai L, Guo C, Kothandaraman N, Koh SC, Zhang H et al. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia 2007;9:1-7.